Happy to sign off on these if no further dilution is required to fund Hillgrove CAPEX.
HK Ignite conf, RH mentioned a target 60/40 split for a debt / equity raise (in itself a very price sensitive disclosure). $40m equity raise would lead to another 10-15% dilution on current SOI within a band of 60c-$1 SP. i.e 40m to 65m additional SOI.
I firmly believe the dynamics for short term price action and the selling last fortnight was a reflection of this risk. In addition to missed deadlines seeing institutions place capital in more proactive assets to capitalise on Au price and rightfully so.
I'm starting to see some chinks in the armor in a pivotal stage of financing and will be looking to sell down my position to profit take when the opportunity arises. Heavy incentives for institutions to cap the share price looking for a predatory cut in the would be raise.
I could be wrong, I don't think I am.
- Forums
- ASX - By Stock
- LRV
- Ann: Notice of Annual General Meeting/Proxy Form
LRV
larvotto resources limited
Add to My Watchlist
3.25%
!
63.5¢

Ann: Notice of Annual General Meeting/Proxy Form, page-20
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
63.5¢ |
Change
0.020(3.25%) |
Mkt cap ! $261.8M |
Open | High | Low | Value | Volume |
66.5¢ | 67.5¢ | 62.0¢ | $2.341M | 3.623M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 63.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
64.0¢ | 64824 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 0.635 |
3 | 139000 | 0.630 |
3 | 77617 | 0.625 |
6 | 178776 | 0.620 |
7 | 39673 | 0.615 |
Price($) | Vol. | No. |
---|---|---|
0.640 | 53478 | 2 |
0.645 | 15000 | 1 |
0.650 | 51500 | 2 |
0.655 | 41815 | 3 |
0.660 | 1280 | 1 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
LRV (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online